Bioresorbable Coronary Scaffolds Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type ( Drug Eluting Coronary Scaffolds, Everolimus-eluting Device (Absorb GT1), Novolimus-eluting Device (DESolve), Sirolimus-eluting Device, Paclitaxel-eluting device ); Material ( Polyglycolic acid (PGA) Polymers, Polyglycolide Polymers, Bioresorbable Magnesium ); End User ( Hospitals, Ambulatory Surgical Centers, Coronary Catheterization Labs ), and Geography

Report Code: TIPRE00019588 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Bioresorbable scaffolds (BRS) were developed as an alternative to drug-eluting stents (DES) to facilitate vessel restoration and reduce the risk of future adverse events, but problems regarding safety and effectiveness of first-generation BRS have restricted their clinical use.

MARKET DYNAMICS

The bioresorbable coronary scaffolds market is driving due to the factors such as increasing number of coronary artery diseases, and rising demand for biocompatible coronary stents. However, challenges with respect to selection of scaffold material and long duration for the degradation of material is likely to hamper the growth of the market to a certain extent.

MARKET SCOPE

The "Bioresorbable coronary scaffolds Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of bioresorbable coronary scaffolds market with detailed market segmentation by product type, material, and end user. The bioresorbable coronary scaffolds market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in bioresorbable coronary scaffolds market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The bioresorbable coronary scaffolds market is segmented on the basis of product type, material, and end user. Based on product type, the market is segmented into drug eluting coronary scaffolds, everolimus-eluting device (absorb gt1), novolimus-eluting device (desolve), sirolimus-eluting device, and paclitaxel-eluting device. Based on material, the market is segmented into polyglycolic acid (PGA) polymers, polyglycolide polymers, and bioresorbable magnesium. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and coronary catheterization labs.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the bioresorbable coronary scaffolds market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The bioresorbable coronary scaffolds market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting bioresorbable coronary scaffolds market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the bioresorbable coronary scaffolds market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the bioresorbable coronary scaffolds market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from bioresorbable coronary scaffolds market are anticipated to have lucrative growth opportunities in the future with the rising demand for bioresorbable coronary scaffolds in the global market. Below mentioned is the list of few companies engaged in the bioresorbable coronary scaffolds market.

The report also includes the profiles of key players in bioresorbable coronary scaffolds market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Amaranth Medical, Inc.
  •  REVA Medical, Inc.
  •  Abbott Vascular Inc.
  •  Elixir Medical Corporation
  •  BIOTRONIK, Inc.
  •  Medtronic
  •  Boston Scientific Corporation
  •  Lombard Medical
  •  Terumo Corporation
  •  KYOTO MEDICAL

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bioresorbable Coronary Scaffolds Market - By Product Type
1.3.2 Bioresorbable Coronary Scaffolds Market - By Material
1.3.3 Bioresorbable Coronary Scaffolds Market - By End User
1.3.4 Bioresorbable Coronary Scaffolds Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIORESORBABLE CORONARY SCAFFOLDS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIORESORBABLE CORONARY SCAFFOLDS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIORESORBABLE CORONARY SCAFFOLDS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIORESORBABLE CORONARY SCAFFOLDS - GLOBAL MARKET OVERVIEW
6.2. BIORESORBABLE CORONARY SCAFFOLDS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BIORESORBABLE CORONARY SCAFFOLDS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRUG ELUTING CORONARY SCAFFOLDS
7.3.1. Overview
7.3.2. Drug Eluting Coronary Scaffolds Market Forecast and Analysis
7.4. EVEROLIMUS-ELUTING DEVICE (ABSORB GT1)
7.4.1. Overview
7.4.2. Everolimus-eluting Device (Absorb GT1) Market Forecast and Analysis
7.5. NOVOLIMUS-ELUTING DEVICE (DESOLVE)
7.5.1. Overview
7.5.2. Novolimus-eluting Device (DESolve) Market Forecast and Analysis
7.6. SIROLIMUS-ELUTING DEVICE
7.6.1. Overview
7.6.2. Sirolimus-eluting Device Market Forecast and Analysis
7.7. PACLITAXEL-ELUTING DEVICE
7.7.1. Overview
7.7.2. Paclitaxel-eluting device Market Forecast and Analysis
8. BIORESORBABLE CORONARY SCAFFOLDS MARKET - REVENUE AND FORECASTS TO 2027 - MATERIAL
8.1. OVERVIEW
8.2. MATERIAL MARKET FORECASTS AND ANALYSIS
8.3. POLYGLYCOLIC ACID (PGA) POLYMERS
8.3.1. Overview
8.3.2. Polyglycolic acid (PGA) Polymers Market Forecast and Analysis
8.4. POLYGLYCOLIDE POLYMERS
8.4.1. Overview
8.4.2. Polyglycolide Polymers Market Forecast and Analysis
8.5. BIORESORBABLE MAGNESIUM
8.5.1. Overview
8.5.2. Bioresorbable Magnesium Market Forecast and Analysis
9. BIORESORBABLE CORONARY SCAFFOLDS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. CORONARY CATHETERIZATION LABS
9.5.1. Overview
9.5.2. Coronary Catheterization Labs Market Forecast and Analysis
10. BIORESORBABLE CORONARY SCAFFOLDS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Bioresorbable Coronary Scaffolds Market Overview
10.1.2 North America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis
10.1.3 North America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Product Type
10.1.4 North America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Material
10.1.5 North America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By End User
10.1.6 North America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Countries
10.1.6.1 United States Bioresorbable Coronary Scaffolds Market
10.1.6.1.1 United States Bioresorbable Coronary Scaffolds Market by Product Type
10.1.6.1.2 United States Bioresorbable Coronary Scaffolds Market by Material
10.1.6.1.3 United States Bioresorbable Coronary Scaffolds Market by End User
10.1.6.2 Canada Bioresorbable Coronary Scaffolds Market
10.1.6.2.1 Canada Bioresorbable Coronary Scaffolds Market by Product Type
10.1.6.2.2 Canada Bioresorbable Coronary Scaffolds Market by Material
10.1.6.2.3 Canada Bioresorbable Coronary Scaffolds Market by End User
10.1.6.3 Mexico Bioresorbable Coronary Scaffolds Market
10.1.6.3.1 Mexico Bioresorbable Coronary Scaffolds Market by Product Type
10.1.6.3.2 Mexico Bioresorbable Coronary Scaffolds Market by Material
10.1.6.3.3 Mexico Bioresorbable Coronary Scaffolds Market by End User
10.2. EUROPE
10.2.1 Europe Bioresorbable Coronary Scaffolds Market Overview
10.2.2 Europe Bioresorbable Coronary Scaffolds Market Forecasts and Analysis
10.2.3 Europe Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Product Type
10.2.4 Europe Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Material
10.2.5 Europe Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By End User
10.2.6 Europe Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Bioresorbable Coronary Scaffolds Market
10.2.6.1.1 Germany Bioresorbable Coronary Scaffolds Market by Product Type
10.2.6.1.2 Germany Bioresorbable Coronary Scaffolds Market by Material
10.2.6.1.3 Germany Bioresorbable Coronary Scaffolds Market by End User
10.2.6.2 France Bioresorbable Coronary Scaffolds Market
10.2.6.2.1 France Bioresorbable Coronary Scaffolds Market by Product Type
10.2.6.2.2 France Bioresorbable Coronary Scaffolds Market by Material
10.2.6.2.3 France Bioresorbable Coronary Scaffolds Market by End User
10.2.6.3 Italy Bioresorbable Coronary Scaffolds Market
10.2.6.3.1 Italy Bioresorbable Coronary Scaffolds Market by Product Type
10.2.6.3.2 Italy Bioresorbable Coronary Scaffolds Market by Material
10.2.6.3.3 Italy Bioresorbable Coronary Scaffolds Market by End User
10.2.6.4 Spain Bioresorbable Coronary Scaffolds Market
10.2.6.4.1 Spain Bioresorbable Coronary Scaffolds Market by Product Type
10.2.6.4.2 Spain Bioresorbable Coronary Scaffolds Market by Material
10.2.6.4.3 Spain Bioresorbable Coronary Scaffolds Market by End User
10.2.6.5 United Kingdom Bioresorbable Coronary Scaffolds Market
10.2.6.5.1 United Kingdom Bioresorbable Coronary Scaffolds Market by Product Type
10.2.6.5.2 United Kingdom Bioresorbable Coronary Scaffolds Market by Material
10.2.6.5.3 United Kingdom Bioresorbable Coronary Scaffolds Market by End User
10.2.6.6 Rest of Europe Bioresorbable Coronary Scaffolds Market
10.2.6.6.1 Rest of Europe Bioresorbable Coronary Scaffolds Market by Product Type
10.2.6.6.2 Rest of Europe Bioresorbable Coronary Scaffolds Market by Material
10.2.6.6.3 Rest of Europe Bioresorbable Coronary Scaffolds Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Bioresorbable Coronary Scaffolds Market Overview
10.3.2 Asia-Pacific Bioresorbable Coronary Scaffolds Market Forecasts and Analysis
10.3.3 Asia-Pacific Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Material
10.3.5 Asia-Pacific Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Bioresorbable Coronary Scaffolds Market
10.3.6.1.1 Australia Bioresorbable Coronary Scaffolds Market by Product Type
10.3.6.1.2 Australia Bioresorbable Coronary Scaffolds Market by Material
10.3.6.1.3 Australia Bioresorbable Coronary Scaffolds Market by End User
10.3.6.2 China Bioresorbable Coronary Scaffolds Market
10.3.6.2.1 China Bioresorbable Coronary Scaffolds Market by Product Type
10.3.6.2.2 China Bioresorbable Coronary Scaffolds Market by Material
10.3.6.2.3 China Bioresorbable Coronary Scaffolds Market by End User
10.3.6.3 India Bioresorbable Coronary Scaffolds Market
10.3.6.3.1 India Bioresorbable Coronary Scaffolds Market by Product Type
10.3.6.3.2 India Bioresorbable Coronary Scaffolds Market by Material
10.3.6.3.3 India Bioresorbable Coronary Scaffolds Market by End User
10.3.6.4 Japan Bioresorbable Coronary Scaffolds Market
10.3.6.4.1 Japan Bioresorbable Coronary Scaffolds Market by Product Type
10.3.6.4.2 Japan Bioresorbable Coronary Scaffolds Market by Material
10.3.6.4.3 Japan Bioresorbable Coronary Scaffolds Market by End User
10.3.6.5 South Korea Bioresorbable Coronary Scaffolds Market
10.3.6.5.1 South Korea Bioresorbable Coronary Scaffolds Market by Product Type
10.3.6.5.2 South Korea Bioresorbable Coronary Scaffolds Market by Material
10.3.6.5.3 South Korea Bioresorbable Coronary Scaffolds Market by End User
10.3.6.6 Rest of Asia-Pacific Bioresorbable Coronary Scaffolds Market
10.3.6.6.1 Rest of Asia-Pacific Bioresorbable Coronary Scaffolds Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Bioresorbable Coronary Scaffolds Market by Material
10.3.6.6.3 Rest of Asia-Pacific Bioresorbable Coronary Scaffolds Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Bioresorbable Coronary Scaffolds Market Overview
10.4.2 Middle East and Africa Bioresorbable Coronary Scaffolds Market Forecasts and Analysis
10.4.3 Middle East and Africa Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Material
10.4.5 Middle East and Africa Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Bioresorbable Coronary Scaffolds Market
10.4.6.1.1 South Africa Bioresorbable Coronary Scaffolds Market by Product Type
10.4.6.1.2 South Africa Bioresorbable Coronary Scaffolds Market by Material
10.4.6.1.3 South Africa Bioresorbable Coronary Scaffolds Market by End User
10.4.6.2 Saudi Arabia Bioresorbable Coronary Scaffolds Market
10.4.6.2.1 Saudi Arabia Bioresorbable Coronary Scaffolds Market by Product Type
10.4.6.2.2 Saudi Arabia Bioresorbable Coronary Scaffolds Market by Material
10.4.6.2.3 Saudi Arabia Bioresorbable Coronary Scaffolds Market by End User
10.4.6.3 U.A.E Bioresorbable Coronary Scaffolds Market
10.4.6.3.1 U.A.E Bioresorbable Coronary Scaffolds Market by Product Type
10.4.6.3.2 U.A.E Bioresorbable Coronary Scaffolds Market by Material
10.4.6.3.3 U.A.E Bioresorbable Coronary Scaffolds Market by End User
10.4.6.4 Rest of Middle East and Africa Bioresorbable Coronary Scaffolds Market
10.4.6.4.1 Rest of Middle East and Africa Bioresorbable Coronary Scaffolds Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Bioresorbable Coronary Scaffolds Market by Material
10.4.6.4.3 Rest of Middle East and Africa Bioresorbable Coronary Scaffolds Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Bioresorbable Coronary Scaffolds Market Overview
10.5.2 South and Central America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis
10.5.3 South and Central America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Material
10.5.5 South and Central America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By End User
10.5.6 South and Central America Bioresorbable Coronary Scaffolds Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Bioresorbable Coronary Scaffolds Market
10.5.6.1.1 Brazil Bioresorbable Coronary Scaffolds Market by Product Type
10.5.6.1.2 Brazil Bioresorbable Coronary Scaffolds Market by Material
10.5.6.1.3 Brazil Bioresorbable Coronary Scaffolds Market by End User
10.5.6.2 Argentina Bioresorbable Coronary Scaffolds Market
10.5.6.2.1 Argentina Bioresorbable Coronary Scaffolds Market by Product Type
10.5.6.2.2 Argentina Bioresorbable Coronary Scaffolds Market by Material
10.5.6.2.3 Argentina Bioresorbable Coronary Scaffolds Market by End User
10.5.6.3 Rest of South and Central America Bioresorbable Coronary Scaffolds Market
10.5.6.3.1 Rest of South and Central America Bioresorbable Coronary Scaffolds Market by Product Type
10.5.6.3.2 Rest of South and Central America Bioresorbable Coronary Scaffolds Market by Material
10.5.6.3.3 Rest of South and Central America Bioresorbable Coronary Scaffolds Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIORESORBABLE CORONARY SCAFFOLDS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. BIORESORBABLE CORONARY SCAFFOLDS MARKET, KEY COMPANY PROFILES
13.1. AMARANTH MEDICAL, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. REVA MEDICAL, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ABBOTT VASCULAR INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ELIXIR MEDICAL CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIOTRONIK, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. MEDTRONIC
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. BOSTON SCIENTIFIC CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LOMBARD MEDICAL
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. TERUMO CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. KYOTO MEDICAL
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Amaranth Medical, Inc.
2. REVA Medical, Inc.
3. Abbott Vascular Inc.
4. Elixir Medical Corporation
5. BIOTRONIK, Inc.
6. Medtronic
7. Boston Scientific Corporation
8. Lombard Medical
9. Terumo Corporation
10. KYOTO MEDICAL
TIPRE00019588
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking